More on Ocera Q2 results

|About: Ocera Therapeutics, Inc. (OCRX)|By:, SA News Editor

Ocera Therapeutics (OCRX -1%) Q2 results: Revenues: $33K; Net Loss: ($7.2M) (-246.1%); Loss Per Share: ($0.46) (+85.8%); Quick Assets: $38.1M (-19.3%).

2014 Guidance: Cash burn: $30M; quick assets on hand sufficient to fund operations through 2016.